Sabra Healthcare REIT (NASDAQ:SBRA) Hits New 52-Week High on Analyst Upgrade

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) reached a new 52-week high during trading on Wednesday after UBS Group raised their price target on the stock from $20.00 to $21.00. UBS Group currently has a neutral rating on the stock. Sabra Healthcare REIT traded as high as $20.70 and last traded at $20.59, with a volume of 3777379 shares. The stock had previously closed at $20.17.

Other equities analysts also recently issued research reports about the stock. Cantor Fitzgerald increased their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “neutral” rating in a report on Tuesday. Truist Financial raised their price objective on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “hold” rating in a research note on Tuesday, January 20th. Weiss Ratings restated a “buy (b)” rating on shares of Sabra Healthcare REIT in a research report on Thursday, January 22nd. Wall Street Zen downgraded Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research report on Friday, January 23rd. Finally, Citigroup boosted their target price on shares of Sabra Healthcare REIT from $21.00 to $24.00 and gave the stock a “buy” rating in a research note on Wednesday. Five analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $21.70.

Hedge Funds Weigh In On Sabra Healthcare REIT

A number of institutional investors have recently bought and sold shares of the company. Principal Financial Group Inc. lifted its holdings in Sabra Healthcare REIT by 21.6% in the fourth quarter. Principal Financial Group Inc. now owns 24,953,351 shares of the real estate investment trust’s stock valued at $472,617,000 after acquiring an additional 4,431,897 shares during the last quarter. Lasalle Investment Management Securities LLC acquired a new stake in Sabra Healthcare REIT in the 4th quarter valued at about $66,938,000. Engineers Gate Manager LP boosted its holdings in Sabra Healthcare REIT by 3,190.3% in the second quarter. Engineers Gate Manager LP now owns 3,179,303 shares of the real estate investment trust’s stock valued at $58,626,000 after purchasing an additional 3,082,677 shares in the last quarter. Norges Bank acquired a new stake in Sabra Healthcare REIT during the 4th quarter worth $57,945,000. Finally, Sumitomo Mitsui Trust Group Inc. grew its position in Sabra Healthcare REIT by 1,019.8% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,005,374 shares of the real estate investment trust’s stock valued at $56,922,000 after buying an additional 2,736,993 shares during the last quarter. 99.40% of the stock is owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Price Performance

The company has a debt-to-equity ratio of 0.90, a current ratio of 4.29 and a quick ratio of 4.29. The company has a 50-day simple moving average of $19.13 and a 200-day simple moving average of $18.82. The stock has a market cap of $5.08 billion, a PE ratio of 31.47, a PEG ratio of 1.61 and a beta of 0.67.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings data on Thursday, February 12th. The real estate investment trust reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.26). The business had revenue of $201.35 million during the quarter, compared to analysts’ expectations of $201.97 million. Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. Sabra Healthcare REIT’s revenue for the quarter was up 16.2% on a year-over-year basis. During the same period in the prior year, the firm earned $0.36 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Sell-side analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 27th. Shareholders of record on Friday, February 13th will be paid a dividend of $0.30 per share. The ex-dividend date is Friday, February 13th. This represents a $1.20 annualized dividend and a yield of 6.0%. Sabra Healthcare REIT’s dividend payout ratio is currently 187.50%.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.